BlackRock U.S. Impact Fund RPRX Holdings History
BlackRock U.S. Impact Fund's Royalty Pharma PLC Holding Summary
As of 2023-07-31, BLACKROCK FUNDS held 8,110.00 shares of Royalty Pharma PLC(RPRX), totaling $254,490.00. This investment constitutes 4.55% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Royalty Pharma PLC(RPRX) stock.
The initial trade took place in 2021Q4. And since then BlackRock U.S. Impact Fund has made 5 purchases of RPRX, at an average price of $37.95, for a total of 11,464.00 shares. In addition, there have been 2 sales at an average price of $40.05 for 3,354.00 shares. Based on historical transaction data and RPRX's current price of $36.01, BlackRock U.S. Impact Fund's estimated gain on his RPRX holdings is $-8,719.23, reflecting a -2.00% gain to date.
BlackRock U.S. Impact Fund RPRX ($36.01) Holding Chart
BlackRock U.S. Impact Fund RPRX ($36.01) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
